Allergy and Immunology · Albany, GA
NPI
1386749117
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
105 Spanish Crt
Albany, GA, 31707
Phone (229) 438-7100
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
12,422 services
Medicare patients, 2024
320
Average age 74
Drug cost, 2024
$2.6M
5,369 prescriptions
Company payments, 2025
$81K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tracy A Bridges was code 95004 (test - miscellaneous), 4,101 times for 52 patients. In total Tracy A Bridges billed 12,422 services in 45 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 4,101 | 52 | $2.56 | $10K |
| 99214 Office E&M - Established | Office | 388 | 242 | $82.80 | $32K |
| 95165 Treatment - Miscellaneous | Office | 199 | 15 | $9.64 | $1,917 |
| 95117 Treatment - Miscellaneous | Office | 161 | 23 | $7.67 | $1,235 |
| 94010 Pulmonary Function Testing | Office | 102 | 71 | $17.21 | $1,755 |
| 95012 Pulmonary | Office | 92 | 64 | $11.74 | $1,080 |
| 99205 Office E&M - New | Office | 41 | 41 | $138.71 | $5,687 |
| 99213 Office E&M - Established | Office | 40 | 35 | $57.22 | $2,289 |
| 99211 Office E&M - Established | Office | 38 | 14 | $14.52 | $552 |
| 70220 Standard X-ray | Office | 23 | 22 | $23.29 | $536 |
| 99204 Office E&M - New | Office | 15 | 15 | $125.14 | $1,877 |
| 71046 X-ray - Chest | Office | 14 | 12 | $17.17 | $240 |
By year: 2022 $127K for 5,925 services; 2023 $118K for 6,167 services; 2024 $181K for 12,422 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 18 | 13 | $30.53 | $549 |
Medicare prescription drug claims, 2024
In 2024, the drug Tracy A Bridges prescribed most often to Medicare patients was Montelukast Sodium, with 925 prescriptions and refills. In total Tracy A Bridges wrote 5,369 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 925 | 1,661 | 213 | $8,790 |
| Levocetirizine Dihydrochloride Generic | 723 | 1,232 | 172 | $6,437 |
| Fluticasone Propionate Generic | 666 | 1,074 | 209 | $11K |
| Azelastine Hcl Generic | 549 | 904 | 216 | $18K |
| Famotidine Generic | 351 | 610 | 80 | $3,096 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 218 | 272 | 38 | $172K |
| Arnuity Ellipta Fluticasone Furoate | 134 | 167 | 27 | $36K |
| Breo Ellipta Fluticasone/Vilanterol | 102 | 110 | 19 | $43K |
| Dupixent Syringe Dupilumab | 99 | 99 | Under 11 | $389K |
| Symbicort Budesonide/Formoterol Fumarate | 98 | 140 | 18 | $31K |
| Azithromycin Generic | 97 | 97 | 44 | $716 |
| Ipratropium Bromide Generic | 93 | 134 | 32 | $5,010 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 84 | 93 | 46 | $1,810 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 79 | 89 | 17 | $57K |
| Cefprozil Generic | 75 | 75 | 62 | $2,554 |
Brand drugs: 1,296 claims; generic drugs: 4,073 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tracy A Bridges $81K ($81K in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $79K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 84 | $79K |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $303 |
| Pfizer Inc. PFE | 16 | $272 |
| GlaxoSmithKline, LLC. GSK | 20 | $263 |
| BioCryst US Sales Co., LLC | 7 | $212 |
| Grifols USA, LLC | 7 | $179 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $176 |
| CSL Behring CSL.AX | 7 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $163 |
| Genzyme Corporation SNY | 6 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.